MAPT and Alzheimer disease: Our laboratory proposed a strategy for AD combination treatment by targeting extracellular Aβ, intracellular phosphorylated tau protein, and the high ROS microenvironment.238 “Cascaded rocket” PNPs with spatiotemporal separation were prepared for co-delivery of PHis, salsalate, and siNF-κB.